Investor List:

Top Pharmaceuticals Series B Investors in New York City (58)

Know someone who's actively diligencing and investing? Add them to this list.
About this list
We’ve compiled a list of the top Pharmaceuticals investors. The goal is to help Founders find the best investors to target and get introduced to.
Photo of Jonathan Rosenbaum, Managing Director at Insight Partners
Jonathan Rosenbaum
Insight Partners·Managing Director
Sweet spot: $25.0M
Range: $10.0M - $350.0M
Investors in New York (NY)
Investors in Pharmaceuticals (Seed), Investors in Pharmaceuticals (Seed), Investors in Education (Seed), Investors in AI (Seed), Investors in SaaS (Seed), Investors in FinTech (Seed), Investors in Education (Seed), Investors in Enterprise (Seed), Investors in AI (Seed), Investors in FinTech (Seed), Investors in SaaS (Seed), Investors in Enterprise (Seed), Investors in Pharmaceuticals (Series A), Investors in Pharmaceuticals (Series A), Investors in Education (Series A), Investors in AI (Series A), Investors in FinTech (Series A), Investors in SaaS (Series A), Investors in Education (Series A), Investors in Enterprise (Series A), Investors in FinTech (Series A), Investors in AI (Series A), Investors in SaaS (Series A), Investors in Enterprise (Series A), Investors in Pharmaceuticals (Series B), Investors in Education (Series B), Investors in Pharmaceuticals (Series B), Investors in AI (Series B), Investors in Education (Series B), Investors in FinTech (Series B), Investors in SaaS (Series B), Investors in Enterprise (Series B), Investors in AI (Series B), Investors in SaaS (Series B), Investors in FinTech (Series B), Investors in Enterprise (Series B), Investors in New York City (Other Lists)
Photo of Philine Huizing, Principal at Insight Partners
Philine Huizing
Insight Partners·Principal
Sweet spot: $25.0M
Range: $10.0M - $350.0M
Investors in New York (NY)
Photo of Sara Nayeem, Partner at Avoro Ventures
Sara Nayeem
Sweet spot: $1M
Range: $100K - $10.0M
Investors in New York City, Investors in Washington (DC)
Photo of Carl  Gordon, Managing Partner at OrbiMed
Carl Gordon
OrbiMed·Managing Partner
Sweet spot: $4.0M
Range: $1M - $75.0M
Investors in New York (NY)
Photo of Justine Potemkin, Investor at New Enterprise Associates (NEA)
Justine Potemkin
Sweet spot: $25.0M
Range: $2.0M - $50.0M
Investors in New York City
Photo of Klaus Veitinger, Venture Partner at OrbiMed
Klaus Veitinger
OrbiMed·Venture Partner
Sweet spot: $4.0M
Range: $1M - $75.0M
Investors in New York (NY)
Photo of Paul Biondi, Partner at Flagship Pioneering
Paul Biondi
Sweet spot: $7.0M
Range: $500K - $15.0M
Investors in New York (NY), Investors in Cambridge (MA), Investors in New Jersey
Photo of Matthew Rizzo, Partner at OrbiMed
Matthew Rizzo
OrbiMed·Partner
Sweet spot: $4.0M
Range: $1M - $75.0M
Investors in New York (NY)